Renew Biotechnologies Publishes Peer-Reviewed Research Advancing Cell-Type-Associated Biomarkers of Neurodegeneration

The publication advances the scientific foundation for Renew's NeuroLens® biomarker platform. PLEASANT GROVE, Utah, Aug. 7, 2026 /PRNewswire/ -- Renew Biotechnologies today announced the publication of its peer-reviewed research in Frontiers in Neurology, providing evidence that native...